



SU+ @ Strathmore 
University Library  
  
 





Factors associated with delay in presentation of 




Njambi A. kabura 










Kabura, N. A. (2018). Factors associated with delay in presentation of Cancer patients for 





This Thesis - Open Access is brought to you for free and open access by DSpace @Strathmore  University. It has been accepted for 
inclusion in Electronic Theses and Dissertations by an authorized administrator of DSpace @Strathmore University. For more 
information, please contact librarian@strathmore.edu 
This thesis is available for Library use on the understanding that it is copyright material and that no 
quotation from the thesis may be published without proper acknowledgement. 
FACTORS ASSOCIATED WITH DELAY IN PRESENTATION OF CANCER 












SUBMITTED IN PARTIAL FULFILMENT OF THE REQUIREMENTS FOR THE 
DEGREE OF MASTERS IN BUSINESS ADMINISTRATION IN 

















I declare that this work has not been previously submitted and approved for the award of a 
degree by this or any other university. To the best of my knowledge and belief, the dissertation 
contains no material previously published or written by another person except where due 
reference is made in the thesis itself.  
 









The dissertation of Ann Kabura was reviewed and approved by:  
 
 
Dr. Vincent Okungu (Supervisor)  
Strathmore Business School  
 
 
Dr. George Njenga  
Dean, Strathmore Business School  
 
 
Prof. Ruth Kiraka  






The global burden and threat of non-communicable diseases constitute one of the major 
challenges for development in the twenty-first century which undermines social and economic 
development throughout the world. A huge proportion of deaths due to non-communicable 
diseases, including cancer, occur in the low and middle income countries. Cancer is among the 
top five causes of mortality in Kenya. Its estimated annual incidence is close to 37000 and 
unfortunately close to 80% of the patients is diagnosed at an advanced stage. The economic 
impact of cancer is felt at an individual and most importantly a population level. Shortening the 
interval between onset of symptoms and initiation of treatment would greatly improve patient 
outcomes and also reduce the cost of more aggressive treatment. Understanding the pathways to 
care is critical for interventions to be made in a timely manner. An assessment of patients‟ 
perspectives guides strategic decision making to meet expectations and effectively manage 
health care performance. 
The main aim of this study was to identify the factors associated with late cancer diagnosis 
among patients presenting for treatment at Kenyatta National Hospital. 
A descriptive cross-sectional design was used for this study. The study was undertaken at 
Kenyatta National Hospital‟s Cancer Treatment Center. Standardized questionnaires were 
administered to all eligible and consenting patients with either stage three or four of cancer 
presenting for treatment at the cancer treatment center. Patients‟ records were also reviewed to 
ascertain the diagnosis, stage and type of cancer. The data collected was summarized and 
analyzed using Microsoft Excel and MINITAB 14.  
Female respondents were more than the male respondents. The mean age of the respondents was 
49 years; 87% of the respondents were below 65 years old. 71% had attained only primary 
education, 10% had attained tertiary education. Most of the respondents (74%) resided in rural 
areas and 84% of them were in the informal sector. 87% had no pre-existing illnesses and only 
23% were smokers. 65% of them had no prior knowledge on cancer, 71% were unaware of 
measures to reduce the risk of cancer and only 19% had been previously screened for cancer. 
78% of the participants had experienced their symptoms for more than 6 months before the 
diagnosis of cancer was made. 58% of the participants initially sought help for their symptoms in 
private hospitals and 45% had their diagnosis made in private hospitals. 55% had their diagnosis 
made in secondary and tertiary public hospitals. 61% waited for more than 6 months before 
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getting their diagnosis of cancer and a similar proportion had to wait for more than 3 months 
before initiation of treatment. Long waiting time for specialized treatment was identified as the 
main reason for delay.  
The findings of this study corroborate those of other similar studies. The success of any cancer 
control programs will require well-coordinated demand-side and supply-side efforts to address 
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Patient delay is the interval from the onset of symptoms to the initial consultation or 
presentation to a healthcare practitioner.  
Doctor delay will refer to delay in primary healthcare facilities where patients first present, 
where the health care practitioner fails to correctly identify and act upon possible symptoms of 
cancer. 
A healthcare practitioner refers to any healthcare worker that may interact in a treatment setup 
with patients such as doctors, dentists, nurses, pharmacists and clinical officers.  
System delay is the delay occurring from the patient‟s interaction with the health care system; at 
the point where the patient‟s symptoms begin to be investigated (after the initial consultation 
with a provider), to appropriate referral for further investigations and initiation of treatment. This 
can occur at any level of care within the healthcare system. 
Advanced cancer refers to cancer that has spread to other places in the body and usually cannot 
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1.1 Background to the study 
The increasing global burden of non-communicable diseases (NCDs) has become one of the 
major challenges for development in the twenty-first century. NCDs undermine social and 
economic development throughout the world and threaten the achievement of internationally 
agreed development goals such as the 2030 Agenda for Sustainable Development  that seek to 
ensure healthy lives and promote economic development, by reducing the number of preventable 
deaths by a third by 2030 (United Nations, 2015). According to the World Health Organization 
(WHO), NCDs kill 40 million people each year, which is equivalent to 70% of all deaths 
globally. Cardiovascular diseases account for most NCD deaths, (17.7 million people annually), 
followed by cancers (8.8 million), respiratory diseases (3.9million), and diabetes (1.6 million). 
These 4 groups of diseases account for over 80% of all premature NCD deaths. Each year, 15 
million people between the ages of 30 and 69 years worldwide die from NCD related 
complications; over 80% of these premature deaths occur in low- and middle-income countries 
(WHO, 2017). Non-communicable diseases are thus now recognized by the United Nations and 
WHO as a major public health crisis; and cancer care in low- and middle income countries 
(LMICs) is now acknowledged as a global health priority (WHO, 2011).  
 
There is however, still insufficient data on NCDs, particularly in low- and middle-income 
countries. This is because the levels and capacities for reporting and surveillance are still very 
low in these countries. Over the past three decades, deaths from NCDs have increased at an 
astonishingly fast rate in LMICs and as a result, most of these countries are now suffering from a 
double burden of disease. This means that the already over-stretched public health services now 
have to also cope with the increasing trend of NCDs. A large proportion of people with high risk 
of NCDs in LMICs remain undiagnosed, and even those diagnosed have insufficient access to 
treatment at the primary health-care level (WHO, 2017).  
 
Between 30-50% of cancers are preventable by healthy lifestyle choices such as avoidance of 
tobacco and public health measures like immunization against cancer causing infections such as 
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Human Papillomavirus (HPV) associated with cervical cancer; others, such as those that present 
with lumps or abnormal bleeding, can be detected early, treated and cured (WHO, 2017). Even 
with late stage cancer, the suffering of patients should be relieved with good palliative care. 
Late-stage presentation and inaccessibility of diagnosis and treatment resources are common. 
Low income countries are faced with challenges such as lack of adequate pathology services and 
treatment services (WHO, 2017).  
 
The disparity in access to care and outcomes between countries is staggering. The predominant 
causes of the disparities are inadequate health coverage and low individual (or household) 
socioeconomic status (National Cancer Institute, 2008). Higher mortality rates are seen in LMICs 
and according to Globocan higher incidences of cancer and related mortalities are expected to be 
seen in these countries (IARC, 2012). In middle-income countries, cancer treatment centers exist, 
but most of them are located in urban areas (Cazap, Magrath, Kingham, & Elzawawy, 2016). 
Many people have little understanding of cancer, and in some cultural barriers keep others from 
seeking treatment. This, coupled with the cost of transportation and treatment and, frequently, 
the failure of the primary health care provider to recognize the possibility of cancer, results in an 
unknown fraction of patients with cancer dying before reaching a treatment facility. Because of 
these barriers, diagnosis is usually late such that the assumption that cancer is almost invariably 
fatal becomes a self-fulfilling prophecy. Three general barriers to cancer care have been 
identified as cost, education and access (Cazap et al., 2016). 
 
Kenya‟s Ministry of Health in 2017 estimated the annual incidence of cancer in Kenya at nearly 
37000 new cases, with an annual mortality of 28000 (MOH, 2017). The risk of getting cancer 
before 75 years is 14% and the risk of mortality from cancer approaches 12%. Cancer is 
estimated to be the third leading cause of mortality in Kenya and accounts for 7% of overall 
national mortality among the NCDs (WHO, 2014b). 
 
Cancer is among the top five causes of mortality in Kenya. The leading cancers in Kenya are 
breast, cervical, prostate, Kaposi sarcoma and esophageal cancers (MOH, 2017). More than 70% 
of reported cases of cancer are diagnosed at advanced stages when little can be achieved in terms 
of curative treatment (MOH, 2012). The Kenya National Cancer Control Strategy aims at 
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reinforcing health promotion and cancer prevention, improve public awareness of cancer 
symptoms and risks, improve early detection of cancer and expand the treatment resources 
(MOH, 2017). Health promotion programs such as mass cancer awareness campaigns have been 
based on the idea that individuals are purposive and decisive thus providing them with 
knowledge on the illness will promote a change in their health seeking behavior. However, this 
has proven to be insufficient in itself to promote behavior change and thus there‟s need to 
explore the dynamics that influence the well-being of communities. A wide range of factors that 
may directly or indirectly influence health-seeking behavior have been identified. These include 
cultural, social, psychological and economic factors (Mackian, 2003). 
 
In some countries such as in the United Kingdom, there is government policy in place to reduce 
diagnostic delay in all cancers with a focus on public education, screening and referral delay 
(doctor delay). In 2000, the UK government introduced the two-week-wait rule such that a 
general practitioner who suspects cancer should refer the patient within twenty-four hours while 
the secondary care provider should give an appointment for consultation within two weeks 
(Mansell Gemma, Shapley Mark, Jordan Joanne L, 2011; NHS, 2000). The referral guidelines in 
Kenya have neither explicitly described the desirable timelines during the referral of cancer 
patients nor addressed the issue of delay (MOH, 2014). 
 
The time taken from the onset of symptoms to the diagnosis of cancer influences the stage and 
subsequent survival of the patient. Shortening the duration of patient delay would substantially 
improve survival and patient treatment outcomes. Longer time to diagnosis may be detrimental 
in several ways: a more advanced stage at diagnosis, poorer survival, greater disease-related and 
treatment-related morbidity and adverse psychological adjustment. Delays of 3–6 months are 
associated with lower survival. These effects cannot be accounted for by lead-time bias. Efforts 
should be made to keep delays by patients and providers to a minimum (Richards, 2009). It is 
therefore important to understand the patients‟ pathways to cancer diagnosis including the timing 
and the reasons behind help-seeking so as to inform the approaches to reduce delays (Fiona 




1.2 Problem Statement 
Cancer is an important health condition, both in terms of the number of people affected and the 
impacts on those people and the people close to them. Many patients presenting for care at 
cancer treatment centers in Kenya present with advanced disease, including those with vaccine 
preventable cancers such as cervical cancer and those with malignancies that can also be detected 
early due to their usual presentation, such as breast cancer. This situation thus poses a big 
challenge for cancer care in Kenya because when these patients present with such advanced 
disease there is minimal chance for cure.  
From a public health perspective, the economic impact of cancer at the population level is 
significant in terms of the loss of productivity during treatment and after treatment due to the 
adverse effects of cancer treatments, and also due to premature deaths associated with cancer. 
Thus understanding the pathways to care among cancer patients will guide the implementation of 
relevant and timely interventions to curb delays in seeking treatment. Measurement of patient 
experience is important because it provides an opportunity to improve care, enhance strategic 
decision making, meet patients‟ expectations, effectively manage and monitor health care 
performance, and document benchmarks for health care organizations. Measurement of patient 
experiences can also inform an organization on improvement of processes and clinical outcomes, 
utilization of resources, and enhancement of safety (LaVela & Gallan, 2014). 
Several studies have been undertaken in various parts of the world to elucidate the possible 
causes of delays in presentation for cancer care but such research is minimal to non-existent in 
the Kenyan setting. This study thus sought to identify and describe the factors associated with 
delayed presentation of cancer patients for diagnosis and treatment. 
 
1.3 Objectives 
1.3.1 Main Objective 
To examine the factors associated with delay in presentation for treatment among cancer patients 





 1.3.2 Specific Objectives 
The specific objectives of this study are: 
i. To assess the average time to initial presentation for treatment after onset of 
symptoms by cancer patients; 
ii. To examine the socioeconomic and demographic factors that contribute to delays in 
treatment among the cancer patients; 
iii. To examine the role of patients‟ knowledge about cancer in delay for treatment; 
iv. To document health system factors that contribute to late presentation of cancer 
patients for treatment. 
 
1.4 Research Questions 
This study therefore attempts to answer the following questions: 
i. What is the average duration of patient delay among patients presenting for cancer 
treatment at Kenyatta National Hospital? 
ii. What are the socioeconomic and demographic factors associated with delays in cancer 
treatment among patients presenting at the Kenyatta National Hospital? 
iii. How are patients‟ knowledge and attitudes about cancer related with delays in 
presentation for cancer treatment in Kenya? 
iv. What are the health system factors associated with delayed presentation for cancer 
treatment in Kenya? 
 
1.5 Justification of the study 
By understanding the patient‟s perspective regarding delays in seeking treatment, the findings of 
this study will serve as a guide in the making of cancer policies and guidelines by the Ministry of 
Health and thus formulate the relevant interventions to increase cancer awareness and 
responsiveness among Kenyan citizens and health care providers. The ministry will also be in a 
position to advance the formulation of relevant referral guidelines to necessitate timely referral 
of all patients diagnosed with cancer to facilities that are well equipped (in human resource and 
infrastructure) to manage cancer; and in capacity building to ensure that all regional referral 
facilities are well equipped to initiate cancer management, both diagnosis and treatment, in a 
timely manner. This will effectively reduce the numbers of patients waiting in line to commence 
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treatment at the two major referral facilities, that is, Kenyatta National Hospital and Moi 
Teaching and Referral Hospital. 
The health facilities providing diagnostic and treatment services to cancer patients will 
understand better their role in reducing undue delay among cancer patients and consequently 
streamline their processes and systems to reduce inefficiencies. 
Health care practitioners will be trained on early identification of possible symptoms of cancer 
(through the Ministry of Health) and appropriate referral practices thus minimize the doctor 
delay in cancer diagnosis and treatment. 
Patients will be better equipped through cancer awareness programs to understand and identify 
probable symptoms of cancer and thus seek health care in a timely manner. This will improve 
their chances of survival and thus productivity within the economy. It will also reduce their 
healthcare spending and thus avoid the incidents of catastrophic spending in purchase of 
healthcare. The possibly improved outcomes will also lead to reduced psychological distress to 
the patients and their families. 
The associated systemic changes will result in better cancer care outcomes in Kenya, less cancer 
related morbidity and mortality, and thus overall positively contribute to the economic 








Delay in presentation for cancer treatment has been extensively studied over the past years. The 
concept of delay was introduced in 1938 by Pack and Gallo (Pack & Gallo, 1938). Patient delay 
was defined as the interval between onset of symptoms and the initial presentation to the 
physician. They termed the delay as reasonable when the interval was less than three months and 
undue when the interval exceeds three months. Subsequent delay was described to arise from 
refusal to accept the physician‟s advice or delay in acting on the advice(Pack & Gallo, 1938). 
Delay in seeking help for treatment has also been demonstrated for other conditions aside from 
cancer such as in antenatal care (Manda-Taylor L, Sealy D-A, 2017). 
 
A literature review of studies on cancer delay was conducted on data published in English 
journals up to date. Searches were made using various databases such as PubMed, Scielo 
electronic databases among others for a combination of terms such as: cancer delay, cancer 
experience and cancer help-seeking behavior, factors leading to delay in presentation for cancer 
treatment. References from relevant studies were also used to trace other studies.  
This literature review explores the three dominant themes of the research questions. First studies 
done to assess the duration of delay, that is the time interval between onset of symptoms and 
initial presentation for treatment and the interval that follows till initiation of treatment, are 
reviewed. Patient factors associated with delay have been divided into the individual or 
behavioral factors and socioeconomic and demographic factors. Finally significant studies on 
health system (and physician) factors leading to delay in treatment have also been reviewed.  
 
2.2 Theoretical Review 
Several models of the diagnostic pathway have been used to describe the stages from the onset of 
symptoms to initiation of treatment. The diagnostics pathway has thus been divided into three 
component intervals termed as patient delay, doctor delay and system delay depending on the 
point at which the delay occurs (Rikke Pilegaard Hansen, Olesen, Sørensen, Sokolowski, & 
Søndergaard, 2008; Olesen, Hansen, & Vedsted, 2009; Fiona Walter et al., 2012). Patient delay 
may occur when the patient does not interpret the signs and symptoms appropriately and thus 
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fails to react in a timely manner. Doctor delay may occur when a healthcare provider, at the 
primary healthcare level, does not evaluate the patient adequately to consider the possibility of 
cancer and provides the wrong management for the patients‟ symptoms. System delay is about 
the clinical pathways that are initiated upon the initial consultation with the healthcare provider, 
the investigations, and referral until the diagnosis of cancer is confirmed and the appropriate 
treatment instituted (F Walter, Webster, Scott, & Emery, 2012). 
 
Figure 1Categorization of delay 
 
 
 Source: (Rikke Pilegaard Hansen et al., 2008) 
 
2.3 Empirical Review 
2.3.1 Duration of delay 
Malaysian study defined presentation delay as time taken from symptom discovery to first 
presentation of more than three months, diagnosis delay as time from presentation to diagnosis of 
more than a month and treatment delay as time from diagnosis to initial treatment of more than 
one month (Mujar et al., 2017). Determination of the duration of patient delay is challenging 
because it is dependent upon the patient‟s ability to recall which may not be accurate and  the 
onset of symptoms may have been gradual (Brousselle et al., 2017; Weller et al., 2012). 
According to a Danish population-based cohort study, the median total delay (duration from 
initial onset of symptoms to diagnosis and treatment) was ninety-eight days. Most of this delay 
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was due to patient delay (median twenty-one days) and system delay (median fifty-five days) 
while doctor delay was insignificant. The total delay was shortest in breast and ovarian cancer 
and longest in prostate and bladder cancer (Rikke P. Hansen, Vedsted, Sokolowski, Søndergaard, 
& Olesen, 2011). More than 89% of breast cancer patients in Uganda‟s Mulago National Referral 
Hospital delayed more than three months (with an overall median of thirteen months) before the 
first consultation after noticing symptoms (Odongo, Makumbi, Kalungi, & Galukande, 2015). 
An earlier study done in Uganda had indicated an average delay of twenty nine months (median 
twelve months) among breast cancer patients and the delay was worse among rural patients 
(Galukande, 2014). A study done to assess the variation in promptness of presentation in patients 
with one of eighteen cancers described prompt presentation as being less than fourteen days and 
non-prompt presentation as fifteen or more days. The overall median patient interval was ten 
days (Keeble et al., 2014). 
 
A retrospective observational study conducted in a primary care setting concluded that there is 
considerable delay in the management of colorectal cancer, especially in time to consultation and 
time to initiation of treatment. The median duration from onset of symptoms to initiation of 
treatment (total delay) was 138 days (Van Hout, de Wit, Rutten, & Peeters, 2011). A Colorectal 
Cancer Study conducted at Cross Cancer Institute in Edmonton, Alta, revealed that 51% of 
symptomatic patients delayed seeking medical advice for more than one month (Tomlinson, 
Wong, Au, & Schiller, 2012). 
Among patients with non-small cell lung cancer patient delay was found to be 49.9+/-96.9 days, 
doctor delay was 87.7+/-99.6 days, and total delay was 131.3+/-135.2 days. The referral delay 
was 61.6+/-127.2 days and the diagnostic delay was found to be 20.4+/-44.5 days (Yurdakul et 
al., 2015). 
 
Studies have also shown that the duration of delay depends on the tumor location. One study 
revealed the longest median duration to presentation with head and neck cancers (thirty days) 
and the shortest with bladder cancer (two days) patients with prostate and lung cancer were 
referred much later compared to other tumors with breast cancer patients experiencing the 
shortest delays in referral (Baughan, O‟Neill, & Fletcher, 2009). In a separate study, prompt 
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presentation was more frequent in patients with bladder and renal cancer and least frequent in 
head and neck cancers (Keeble et al., 2014). 
 
2.3.2 Patient (individual and behavioral) characteristics associated with delayed 
presentation 
A qualitative study done to study delay among women reporting symptoms of breast cancer 
concluded that help-seeking behavior is influenced by a mixture of the patient‟s knowledge, 
perceptions, beliefs and attitudes (Burgess, Hunter, & Ramirez, 2001). The study suggested that 
the most important step in seeking help for women with breast cancer is in symptom 
identification. Women who experienced unexpected symptoms of breast cancer such as breast 
pain without a breast lump were more likely to delay in seeking help. Other women with 
seemingly „ambiguous symptoms‟ chose not to bother their GP with „unnecessary consultations‟. 
Some women expressed their fear of the likely medical interventions as their reason for delaying 
to seek help while some delayed seeking help due to other competing priorities such as work or 
family (Burgess et al., 2001). 
 
Patients may also tend to trivialize their symptoms or look for easier alternatives such as over the 
counter medication to manage symptoms thus delay in seeking appropriate diagnosis and 
treatment (Tomlinson et al., 2012). A cross-sectional study done to assess cancer awareness and 
barriers to medical help-seeking among Scottish adolescents showed that awareness of signs and 
symptoms of cancer is low and barriers to seeking medical help are high in this age group and 
are influenced by contextual (for example, ethnicity, gender, knowing someone with cancer), and 
emotional (for example, anxiety, fear, worry) factors (Hubbard et al., 2014). 
 
A systematic literature review of studies conducted in Egypt, Nigeria, Ghana, Kenya and Libya 
identified the factors contributing to late presentation of breast cancer among most African 
women as negative symptom interpretation, fear, belief in alternative medicine, social relations 
and networks, lack of trust and confidence in orthodox medicine, and access to healthcare 
(Donkor et al., 2015). A South African study showed that patients‟ fear of treatment modalities 
and associated adverse effects contributed more to delays than socioeconomic or demographic 




According to reports from two systematic reviews across cancer sites, non-recognition of 
symptom seriousness is the main patient-mediated factor resulting in increased time to 
presentation. Fear of cancer is a contributor to delayed presentation, while sanctioning of help 
seeking by others can be a powerful mediator of reduced time to presentation (Macleod, 
Mitchell, Burgess, Macdonald, & Ramirez, 2009). Better knowledge of the signs and symptoms 
of cancer may help people recognize possible cancer symptoms and therefore reduce appraisal 
delay, while more positive attitudes towards help-seeking may reduce behavioral delay (Simon, 
Waller, Robb, & Wardle, 2010). In a study conducted among patients with oral and 
oropharyngeal cancers the patients attributed lack of knowledge on oral cancer as the main 
reason for delay. Most patients assumed the symptoms were trivial and expected them to subside 
without much treatment (Rogers, Vedpathak, & Lowe, 2011). Recognition of the risk of cancer 
and persistence of the symptoms motivate help seeking behavior (Quaife et al., 2014; Whitaker, 
Macleod, Winstanley, Scott, & Wardle, 2015). Studies have also shown that when patients have 
better knowledge of the signs and symptoms of cancer, they might be able to recognize the 
cancer symptoms and seek care thus reducing the appraisal delay. Having positive attitudes 
towards help-seeking could also contribute to reducing behavioral delay (Simon et al., 2010). In 
addition to symptom misattribution, patients also cited other reasons such as the patients‟ social 
responsibilities as barriers to earlier presentation(Scott, Grunfeld, Main, & McGurk, 2006).  
 
The use of Complementary and Alternative Medicine (CAM) among patients has also been 
shown to be associated with delays in presentation and diagnosis (Mujar et al., 2017). Studies 
have also shown the association of cultural beliefs and acculturation with delays in presentation 
(Tejeda, Gallardo, Ferrans, & Rauscher, 2017).  
 
A thematic review of studies on delay among cancer patients, cases at the National Reporting 
and Learning System and consultation with relevant stakeholders in the United Kingdom was 
conducted by the NHS for the period between 2000 and 2008 identified the main risk factors in 
patient delay as symptom recognition and interpretation, psychological and behavioral factors 




2.3.3 Patients’ socioeconomic and demographic differences associated with delay 
Late presentations and higher mortality from cancer have been found among people of lower 
socioeconomic background and from ethnic minority populations (Waller et al., 2009). Ethnic 
minorities and people living in poverty frequently present with advanced cancer (Haynes, 
Smedley, & IoM(U.S.), 1999). Lack of symptom knowledge and awareness, fearful and fatalistic 
beliefs and emotional barriers were found to be more frequent in people within lower 
socioeconomic groups.  These were found to contribute to prolonged symptom presentation 
among lower socioeconomic groups (McCutchan, Wood, Edwards, Richards, & Brain, 2015). 
 
A retrospective study of delayed presentation among breast cancer patients done in Hong Kong 
concluded that delayed presentation was contributed to by socio economic/demographic factors 
such as low level of education and awareness of cancer, low family income and also a limited 
access to public health facilities since most citizens cannot afford private health care(Yau et al., 
2010). There is strong evidence of an association between older age and patient delay for breast 
cancer, between lower socio-economic status and delay for upper gastrointestinal and urological 
cancers and between lower education level and delay for breast and colorectal cancers (Macleod 
et al., 2009). With less regular follow-up, patients with low socio-economic status have a two-
fold risk of having late stage breast cancer regardless of cancer characteristics and detection 
mode (whether during screening or due to presence of clinical signs) (Orsini, Trétarre, Daurès, & 
Bessaoud, 2016). 
 
A population-based breast cancer screening program was implemented in the Central Denmark 
Region in 2008–2009 with the objective to examine the association between socio-demographic 
characteristics and screening participation. Non-participation was associated with older age, 
immigrant status, low OECD-adjusted household income, high and low level education 
compared with middle level education, unemployment, being unmarried, distance to screening 
site >20 km, being a tenant and no access to a vehicle. Clients from socially deprived 
backgrounds were also more likely to be passive than active participants (Flytkjaer Jensen, 
Fischer Pedersen, Andersen, & Vedsted, 2012). More advanced and metastatic cancer is more 
likely in women who are higher deprivation groups and rural areas. Women who attend public 
hospitals and also those who miss out on screening events are more likely to have more advanced 
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cancers at diagnosis. This may be due to patient level or system level barriers that hinder access 
to healthcare (Seneviratne et al., 2016). 
 
Postmenopausal women with shorter education, lower disposable income, no access to organized 
mammography screening and who were residents of rural areas were more likely to be diagnosed 
with higher risk breast cancers (Dalton et al., 2006). Delay among women with breast cancer is 
worst among patients with no social support (Odongo et al., 2015). Young patients, ethnic 
minorities and women also experience longer physician delays (Georgios Lyratzopoulos, Neal, 
Barbiere, Rubin, & Abel, 2012). 
 
Patients with medical insurance were found to be less likely to present with advanced disease 
(stage III/IV) than those without for some cancers such as lung and prostate but not for breast or 
colorectal cancers where presentation times were similar (McCarthy et al., 2007).  
 At Kenyatta National Hospital, women with advanced stages of cervical cancer were more 
likely to be single, HIV positive, older (50-75 years) and have lower levels or no education 
(Makena Frida, Carole Atieno, & Habtu, 2017). Similar findings have been shown among 
Danish patients with cervical cancer (Ibfelt et al., 2012). 
 
Some studies have showed a relationship while in others there was no relationship between 
factors such as marital status, education and income with patient delay. According to one study 
women who were employed and those who smoked experienced longer patient delay than 
women who were retired and those who did not smoke, but there were no specific socio-
economic predictors for patient delay in men (Minghella E, Lakhani M, Hughes C, 2010). 
According to Hansen et al. socioeconomic predictors of delay could be used to hypothesize 
social inequalities in the distribution of delay, but, in general, only a few socioeconomic 
variables predicted delay in cancer diagnosis. The authors suggested that future research should 





2.3.4 Health system factors associated with delayed presentation 
Pack and Gallo suggested that criticism on the part of the physician was based on the action 
taken after reviewing a patient with symptoms rather than solely on the time elapsing from 
presentation to initiation of treatment. They described five criticisms according to the type of 
error: wrong treatment, wrong advice, no treatment and no advice, acceptable treatment but delay 
in referring when no improvement results, and inability to diagnose within a month. They thus 
recommended that training of the medical practitioners in first contact with patients is very 
important to enable them to make early and correct diagnoses of cancer (Pack & Gallo, 1938). 
 
Prolonged waiting times for review by medical specialists and for the diagnosis to be made also 
significantly contribute to the delay. Upon review of patients, physicians have also been guilty of 
conducting inadequate physical examinations on the patients thus a number may fail to diagnose 
cancer in a timely manner (Tomlinson et al., 2012). Inaccessibility of healthcare professionals 
greatly contributes to prolonging the delay (Scott et al., 2006). 
 
Misdiagnosis occurring either through treating patients symptomatically or relating symptoms to 
an existing health problem other than cancer was found to be an important theme across cancer 
sites. For some cancers, this could also be linked to inadequate patient examination, use of 
inappropriate tests or failing to follow-up negative or inconclusive test results (Macleod et al., 
2009). 
 
The type of cancer was found to contribute to physician delay in a data analysis conducted in 
England based on the 2010 National Cancer Patient Experience Survey.  This analysis revealed 
that patients with multiple myeloma, pancreatic cancer, stomach cancer and lung cancer were 
more likely to have had three or more pre-referral consultations while patients with breast 
cancer, melanoma, testicular cancer and endometrial cancer were more likely to have been 
referred after one or two consultations (Georgios Lyratzopoulos et al., 2012). 
 
Sally Brown et al suggested that health system factors that may contribute to delays in diagnosis 
hence poorer outcomes may include centralization of services, free movement of patients 
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between primary providers, access to secondary care and the existence of patient list systems. 
They however did not establish a causal correlation between healthcare system characteristics 
and cancer outcomes (Brown et al., 2014). 
 
A qualitative study conducted in Denmark concluded that that merely focusing on the patient in 
order to understand care-seeking decisions draws attention away from issues such as power and 
social control in the clinic, but also wider societal issues such as the economic and organizational 
aspects of health care (Andersen, Vedsted, Olesen, Bro, & Søndergaard, 2011). Missed 
opportunities for diagnosis of cancer may occur anywhere along the diagnostic pathway due to 
reasons such as rigid consultation norms, inadequate history and physical examination, language 
barriers, comorbidity, long waiting times, referral norms, patients‟ failure to take medical advice, 
complex diagnostic pathways and lack of follow up of abnormal or borderline normal results (G 
Lyratzopoulos, Vedsted, & Singh, 2015). 
 
Healthcare provider delay has been shown to be related to initial misdiagnosis and insufficient 
examination by the practitioner. Some physicians may attribute symptoms to a non-cancer cause 
and fail to treat accordingly. Inconclusive or false negative test results have also been seen as 
factors causing delays. Patients who did not see their GP prior to diagnosis (those attending 
screening, presenting to A&E or secondary care) had shorter delays than those who consulted 
their GP. Co-morbidity may contribute to delay with GPs attributing the symptoms to the 
existing disease, though it has also been shown to prompt earlier referrals. Patient characteristics 
were also identified as having some influence on provider delay; men experienced longer doctor 
delays, and women with a larger household fortune experienced the shortest delay. Similarly, 
older people, those from higher social classes and higher socio-economic groups were referred 
more quickly, although the findings were inconclusive regarding gender (Minghella E, Lakhani 
M, Hughes C, 2010).  
 
Healthcare system delay is under-researched but there is evidence to suggest that, even with 
improved diagnostic and treatment pathways in cancer, there are still problems with: waiting 
times for tests; waiting times for non-urgent referrals; administrative delays for follow up 
(leading to increased patient delays). Implementing referral guidelines and developing a faxable 
16 
 
urgent referral pro forma along with educational meetings reduced average waiting times 
(Minghella E, Lakhani M, Hughes C, 2010). 
 
2.4 Conclusion 
Most of the studies conducted have focused on patient delay and reveal that patient factors 
associated with delay play a huge role in the delayed presentation for cancer treatment. Patients‟ 
lack of awareness of cancer symptoms leads to lack of recognition and misattribution which 
adversely affect the duration prior to diagnosis and institution of treatment. Socially deprived 
(the poor, less educated, low socio-economic status) patients are more likely to experience delays 
in cancer diagnosis and treatment. However, the contribution of health provider and the health 
system to the delay cannot be overlooked. Unsuspecting healthcare workers may attribute 
patients‟ symptoms to other causes aside from malignancy and thus fail to adequately 
investigate, refer or initiate treatment. In countries with a shortage of cancer specialists and 
treatment facilities patients face delays due to prolonged waiting times. The material drawn in 
this review will provide direction in the formulation of the conceptual framework and the data 
collection tools. 
 
2.5 Conceptual Framework 
Many studies have focused on patient delay as the most significant factor in delayed presentation 
for cancer treatment. However, some studies have also shown that delay can also be attributed to 
some healthcare provider and system factors.  
 
In this study the independent variables are patient factors classified into socio-demographic and 
individual factors. These interact with the intervening factors (health system-related factors) and 
lead to either early or delayed diagnosis of cancer. Older age, for example, has been associated 
with longer delay in seeking health due to various reasons such as lack of adequate social 
support. Older patients are more likely to have comorbidities hence probable cancer symptoms 
maybe inadequately evaluated and often dismissed as sequelae of the other existing illnesses 













This study sought to assess the factors associated with delays in cancer treatment and 
consequently contribute to the ongoing dialogue and efforts in cancer control in Kenya. This 
section describes the methodologies, the study area including the population and study tools. 
Ethical issues pertaining to the study are also mentioned here and how they were handled. 
 
3.2 Study design  
This study employed a descriptive cross-sectional design. Descriptive studies literally describe 
the phenomenon of interest and observed associations in order to estimate certain population 
parameters such as prevalence, for testing hypotheses, and for generating hypotheses about 
possible cause and effect associations between variables(Bowling, 2014). This design was 
chosen for this study because the study aimed at identifying and describing factors among the 
patients with advanced stages of cancer that could have contributed to their delay in diagnosis 
and treatment. Cross-sectional surveys are also easy to undertake and economical in terms of 
time and resources, and the standardized data collected are easily coded for analysis.  
A structured questionnaire tool was administered to all consenting patients to generate data that 
was used to assess the demand-side factors influencing cancer treatment seeking behavior. A 
structured questionnaire enables the collection of unambiguous and easy-to-count answers for 
quantitative data (Bowling, 2014). 
 
3.3 Sampling 
3.3.1 Study setting and Population 
This study was carried out at the Kenyatta National Hospital‟s Cancer Treatment center. 
Kenyatta National Hospital is Kenya‟s main public referral facility and is located in Nairobi‟s 
Upper Hill area. It has a bed capacity of 2000 inpatients with an average annual outpatient 
attendance of 600,000 and annual inpatient attendance of approximately 89,000. KNH was 
purposely selected as it is the only public facility with the capacity to offer comprehensive 
cancer treatment services that include diagnosis, surgery, chemotherapy, hormonal therapy and 
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immunotherapy, radiotherapy (2D, 3D and Brachytherapy, radioactive iodine treatment, and 
palliative care services. The other public cancer treatment facilities are Moi Teaching and 
Referral Hospital in Eldoret and Coast Provincial general hospital in Mombasa, which offer 
surgery, chemotherapy and palliative care services. Patients who can afford private health care 
can also access comprehensive cancer treatment at private facilities such as Nairobi Hospital, MP 
Shah, Aga Khan University Hospital and Texas Cancer Center, all located within Nairobi. 
The KNH cancer treatment center thus attracts high numbers of cancer patients from rural and 
urban areas all over the country and the East African region. The cost of treatment is lower than 
in private facilities within the region thus KNH serves a socioeconomically diverse population 
mostly from the middle and the lower socioeconomic classes.  
The cancer treatment center has had an almost constant number of five specialists and five 
medical officers for a long time which is grossly inadequate to serve all these patients. Many 
cancer patients in the country will almost invariably end up at KNH for treatment. This is 
because KNH may be the only affordable option for those unable to afford private healthcare and 
also for those who exhaust their finances or insurance cover at private facilities. In addition, 
KNH being centrally located in the country‟s capital city makes it easier to access for patient in 
different parts of the country.  
The KNH Cancer Treatment Centre receives between 250-300 new patients from different parts 
of the country every month (Records Department, 2018). This translates to an average of 3,300 
new cancer patients every year. In addition to close to 25,000 patients who are different stages of 
the treatment and follow up cycle also visit the clinic. Cancer is among the leading causes of 
hospitalization at Kenyatta National Hospital. According to the hospital‟s Cancer Registry, 53% 
of the patients admitted in 2015/2016 were due to cancer related morbidity. Mortality due to 
cancer accounted for around 15% proportionate to other diseases. More than 75% of the new 
patients present for treatment at advanced stages, that is, stage three and four disease.  
The target population consisted new patients with advanced stages of cancer (stage three and 
four) presenting for treatment at the cancer treatment center during the month of April 2018. This 
study focused on the patients who were presenting to start their treatment, either chemotherapy, 
radiation therapy or both, after the diagnosis and other investigations had been done. This group 
of patients was chosen because they had undergone the major steps of experiencing symptoms, 
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diagnosis and now starting their treatment and thus they could respond to all sections within the 
questionnaire. 
 
3.3.2 Sampling and Sample Size Determination 
This study used the non-probability purposive sampling method in selection of participants. The 
technique was favorable for this study because of the limited resources, both time and financial, 
that would have been required for a probability sampling technique. The researcher set out to 
identify all patients with stage three and four cancer as they attended the cancer treatment center 
during that period. Each of these patients was taken through the information sheet concerning the 
purpose of the research and was assured of the confidentiality of the information provided. Those 
who agreed to participate in the study then provided their written consent by signing the 





April, 2018. A total of 69 participants participated in this study. 
 
3.4 Eligibility Criteria 
Eligibility criteria included male and female adult patients with histologically proven stage III or 
IV cancer, and ability to communicate in English or Swahili.  
Patients who had previously begun treatment, those below the age of eighteen years and those 
who were too sick to communicate were excluded from the study. 
 
3.5 Data Collection, methods and procedures 
Data collection was by use of standardized questionnaires. The questionnaire was developed 
following the review of other similar studies done elsewhere, including the Cancer Awareness 
Measure from the UK, and also based on the specific objectives of the study. The questionnaires 
consisted mainly of closed-ended questions on bio data such as gender, age, level of education, 
and occupation; awareness of cancer and also had a section on health system factors. Some 
sections included Likert scale type of questions. Patients‟ medical records were also reviewed to 
ascertain the stage of the disease and also when the cancer diagnosis was made which was 




Most patients were assisted in filling the questionnaires by the investigator and the probing was 
done in English or Swahili as appropriate. Application of the questionnaires through face-to-face 
interviews was desirable due to the challenges that may arise with self-administered 
questionnaires among mixed populations of educated patients and others with little formal 
education. Data collection was carried out solely by the primary investigator. Unique patient 
identifiers were used to identify the patients so as to maintain confidentiality. 
 
3.6 Data Management and analysis 
Independent variables of interest were: Demographic details such age, marital status and 
residence; socio-economic details such as education and occupation; individual factors such as 
knowledge and awareness level, smoking and preferences such as for alternative medicine; and 
health system factors such as availability of diagnostic tests, promptness of referral, proximity to 
diagnostic center, accessibility, duration of diagnostic test, and cost of treatment. The dependent 
variable was the late diagnosis and treatment. 
Quantitative data collected was entered into a Microsoft Excel spread sheet for clearance and 
analyzed using the MINITAB 14 statistical package. Descriptive analysis using measures of 
central tendency such as the median and mode, frequencies and range were then calculated and 
summarized in graphs and charts. 
 
3.7 Measures of validity and reliability 
Pre-testing of the questionnaire was done to ensure that it was easy to understand and able to 
elicit the desired responses from the participants. As a result, the section of the questionnaire 
containing the health system factors was edited and reformatted using the Likert-scale type 
questions. 
 
3.8 Ethical Considerations 
The proposal was submitted to the Strathmore University Institutional Ethics Review Committee 
and subsequently, ethical approval was obtained (SU-IRB 0190/18). An information sheet 
containing the purpose of the study, confidentiality and the right not to participate in the study, 
and a subsequent consent form, was prepared and administered to each participant, either in 
English or in Swahili to ensure informed consent. No reference to real identifiers such as 
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patients‟ names or any reference to individual participants was made so as to ensure 




PRESENTATION OF RESEARCH FINDINGS 
4.0 Introduction 
This chapter describes the results obtained from the study. The main objective of this study was 
to examine the factors associated with late presentation of cancer patients for diagnosis and 
treatment at Kenyatta National Hospital. This study targeted adult cancer patients presenting 
with advanced stages of cancer, that is, stage three and four cancers. 
The results are presented in four main sections aligned to this study‟s specific objectives: The 
first section describes the duration of delay prior to consulting a healthcare provider. The second 
section describes the socio-demographic and economic factors associated with delay among the 
patients sampled. The third section highlights knowledge and awareness of cancer and its 
prevention among the participants and the fourth section is about health system factors (doctor 
and system factors) that were significant for delay among these patients. 
All those eligible were confirmed to have either stage three or four of cancer. A total of 69 
patients responded to the questionnaires administered. 7 of the questionnaires were excluded 
from the analysis due to missing responses, thus a total of 62 questionnaires were analyzed. 
The type and stage of cancer was ascertained by reviewing the patients‟ medical records. The 
distribution of the cancer types among the respondents is shown in figure 3 below. The top two 













Figure 3 Stratification of respondents by cancer type  
 
 
4.1 Duration of symptoms prior to consulting a healthcare provider (Patient delay) 
The study assessed the duration that the participants had experienced their symptoms prior to 
consulting a healthcare provider (Figure 4 below).  
From Figure 4, about 78% of the respondents had had their symptoms for more than six months, 
13% had had their symptoms for 3-6 months and 10% had had their symptoms for less than three 
months. 40 respondents (65%) admitted to have used some medication to ease their symptoms 
prior to their diagnosis of cancer. Of these, 29% used over-the-counter (OTC) medicines, 29% 

























Figure 4 Duration of delay 
 
 
The delay (as in figure 5 below) was longest for breast cancer where ten patients delayed for 
more than six months (four of them had delayed to consult a medical practitioner for more than a 
year).  This was followed by cervical cancer where eight patients delayed for more than six 
months. Six patients with head and neck cancer delayed for more than six months before seeking 
medical advice while for the other cancers in the sample the delay ranged from 3-12 months. 
Breast, cervical and head and neck cancers had the highest prevalence and thus correspondingly 
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Figure 5 Duration of delay by cancer type 
 
 
4.2 Socio-demographic and economic characteristics of patients 
The socio-demographic characteristics of interest were age, marital status, residence, education 
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Figure 6 Percentage of patients in each age group 
 
 
From Figure 6, the youngest patient in the study was 30 years while the oldest was 72 years. The 
data was further grouped into 5-year age groups and further analyzed. Eighty-seven percent (58 
patients) of the patients were still in their productive years, that is, below the sixty-five years 
retirement age. The highest number of participants, 22 (35%) was in the 40-49 age group, 
indicating potential high economic losses from the most productive age-groups. 
 
Female participants constituted 68% of the total number of participants, while men were 32%. 
71% of the respondents were married, 13% were single (never married), 13% were separated (or 
divorced) and 3% were widowed. About 58% of them had dependents.  
Majority of the respondents (71%) had only up to primary level education; 16% had attained 
secondary education while only 10% of the respondents had acquired tertiary education. About 
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Figure 3: Percentage number of patients in each age group 
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Figure 7: Education level of the participants 
 
 
Female respondents reported higher education status than the male respondents; 58% of the 
female respondents had attained at least primary level education as compared to 29% of the male 
respondents. 
The study also assessed the residence of the respondents. Out of the forty-seven counties in 
Kenya, the participants in the study only represented 17 counties. Nairobi, Murang‟a, Nakuru 
and Nyeri counties had the highest number of patients with a combined percentage of 49%, and 
Nairobi County where the hospital is based having 19% of the participants. This could be 
explained by the proximity and ease of access of these locations to the Kenyatta National 
Hospital.  
Of all the patients, 74% were from rural areas while only 26% were from urban areas. Overall, 
84% of the respondents were from the informal sector, 13% were from the formal sector and 3% 














Figure 8 Type of residence and source of income 
 
 
From figure 8 above, 71% of those from rural and 13% of those participants from urban 
residences were members of the informal sector. The overall picture indicates the likelihood that 
rural and low-income informal sector cancer patients are more likely to seek treatment from 
public facilities than other population groups. 
Only 14 (23%) of the respondents admitted to a prior history of cigarette smoking. 54 (87%) of 
the respondents had no other pre-existing illnesses beside their diagnosis of cancer and eight of 
them admitted to have had other pre-existing conditions.  
 
4.3 Knowledge of cancer and prevention 
65% of the respondents denied any knowledge of cancer prior to their diagnosis and 
correspondingly, only 23% of the respondents had known someone else with cancer before their 
diagnosis.  
40 respondents (65%) admitted to have used some medication to ease their symptoms prior to 
their diagnosis of cancer. Of these, 29% used over-the-counter (OTC) medicines, 29% 















71% of the respondents had not heard of any measures that could be taken to prevent cancer and 
similarly, only 12 of the respondents, that is, 19% had been screened for cancer before their 
diagnosis.  
When queried on the lack of screening (figure 9 below), 50% reported that they were not aware 
about screening services, 28% said that they thought there is no need for screening and 22% said 
there were no screening services available near their place of residence.  
 
Figure 9 Awareness of cancer screening services 
 
 
A selected number of possible measures to reduce the risk of cancer were adapted from the 
Cancer Awareness Measure CAM (Uk, 2008). These were presented to the participants and by 
use of the Likert scale, the participants were asked to rate the extent to which they agreed with 
the statements.  
Most of the respondents (58) strongly agreed that not smoking and reduced alcohol consumption 
could reduce the risk of cancer. 40 of the respondents agreed that having a balanced diet could 
help prevent cancer and 15 agreed on the need for regular cancer screening. Most (52) were not 
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4.5 Health system factors contributing to delayed care 
In figure 10 below, the majority of the respondents, 36 (58%), presented to private healthcare 
providers after discovering their symptoms. 19% presented to primary public and 19% secondary 
public facilities. Only 3% of the respondents visited tertiary public facilities for evaluation of 
symptoms prior to their diagnosis of cancer.   
 





As seen below in figure 11, 28 of the respondents (45%) had their diagnosis of cancer made at 
private facilities; 39% of them were seen at smaller (primary and secondary level) private 
facilities while 6% had their diagnosis at tertiary private facilities. The rest (34 respondents) had 
their diagnosis made at public health facilities; 35% at secondary level public facilities and 19% 






Figure 5 Type of health facility that participants presented to for initial 
evaluation of symptoms 
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Figure 11 Health care facility where diagnosis was made  
 
 
38 of the respondents (61%) had to wait for more than six months after visiting the health facility 
before knowing that they had cancer. 23% of them waited for a period of 3-6 months and only 
16% of them learnt of their cancer diagnosis within three months of presenting to the health 
facility. 
 
8 of the respondents (13%) received timely initiation of treatment after getting their diagnosis of 
cancer, that is, within two to four weeks after diagnosis. 26% started their treatment in the first 
three months after their diagnosis while the majority, 61% had to wait for more than three 








Health care facility where diagnosis was made 
Primary public level facility
Secondary public facility






Figure 12 Waiting period before initiation of treatment at KNH 
 
 
Health system factors related to delay in treatment were assessed using a 5-point Likert scale 
ranging from 0-5 (strongly disagree, disagree, not sure, agree, strongly agree) .The patients were 
asked to rate the extent to which they agreed with the provided statement. These highlighted 
factors that were associated with either doctor or system delay. Several respondents ( as shown in 
figure 13 below) strongly agreed that insufficient evaluation, wrong diagnosis and treatment, 
delayed referral for specialized care and the medical practitioner not explain the results 
adequately as significant factors in their delay. 
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Long waiting times was ranked as the highest reason for delay among the health system factors. 
38 of the respondents strongly agreed that it was the factor that most contributed to their delay in 
diagnosis and treatment of cancer. Other factors that also featured significantly include 
inaccessibility of care in terms of treatment not being available at nearby facilities or there being 
no facility in the proximity of the patients and 12 respondents said the cost of treatment was 
unaffordable to them. This has been summarized in figure 14 below. 
 






















DISCUSSION OF RESULTS 
 
This study sought to identify the variables associated with delay in treatment of cancer from the 
onset of symptoms based on the responses to the pretested questionnaire. Expectedly, most of the 
respondents in this study were still within the productive age of below sixty-five years. This 
significantly corresponds to the national and international findings on the rising burden of cancer 
among younger populations which adversely affects the productivity especially in developing 
countries like Kenya.  
 
This study revealed a high level of lack of awareness of cancer, the risk factors and information 
on screening among the respondents. Studies have shown that lack of knowledge of the disease 
and measures for prevention are the key barriers to uptake of preventive services like screening 
(Islam, Billah, Hossain, & Oldroyd, 2017). More than seventy percent of the respondents were 
residents in rural settings. A vast majority of the Kenyan population is in the informal sector and 
most of the respondents in this study belonged to the informal sector. Level of education, urban 
living and employment outside the home have been shown to be indices of the opportunity for 
knowledge acquisition (Islam et al., 2017). This majority of Kenyans in the informal sector may 
thus suffer lack of knowledge on cancer and the prevention measures available for them. Some 
organizations also collaborate with healthcare providers to provide screening services to their 
employees which may be unavailable to those in the informal sector. The availability of 
employer-sponsored health insurance schemes also allows members of the formal sector to 
access services such as screening and cancer awareness at the facilities within their coverage. 
People with formal employment also have more education and less cultural barriers to health 
care utilization. Urban populations are more likely than rural populations to be aware of cancer, 
the risk factors, screening, diagnostic and treatment facilities available to them simply due to the 
inequitable distribution of health facilities in Kenya (Kimathi, 2017). More healthcare providers 
prefer urban to rural locations thus significant proportions of rural populations remain largely 




Sixty-eight percent of the respondents with advanced stage of disease sampled in this study were 
female. Women seek more health care than men in response to both physical and mental health 
concerns (Thompson et al., 2016). Some studies have shown that delayed presentation for 
treatment is more likely among patients with little to no social support, while others showed no 
association between marital status and the time to presentation (Pedersen, Olesen, Hansen, 
Zachariae, & Vedsted, 2011). In this study, however, most of the respondents were actually 
married as opposed to being single or widowed. Some studies, however, have shown that women 
are more likely than men to present with advanced disease due to lack of empowerment and the 
existence of highly patriarchal societies however others concluded that there is no significant 
variation between men and women in the use of primary care facilities prior to diagnosis (Wang, 
Freemantle, Nazareth, & Hunt, 2014).  
 
Most of the participants in this study reported no pre-existing illnesses. Studies done in the 
United States showed higher prevalence of comorbidities among cancer patients (Sarfati, 
Koczwara, & Jackson, 2016). This difference may be due to the fact that cancer patients in the 
US present at a much older age than those in Kenya and in particular, in this study, most of the 
patients were below sixty five years. Several studies have shown a higher likelihood for delay 
among patients with other pre-existing illnesses compared to those without because in some 
instances their symptoms may be ignored and attributed to the existing disease processes by the 
patient or the doctor as opposed to a new disease process (Louise, Hill, Collier, & Gemine, 
2017)(Luo et al., 2015).  
 
Smokers are less likely to present early for treatment and are also more likely to have other 
smoking-related comorbidities such as cardiovascular and respiratory illnesses thus 
compounding their risk for late presentation (Louise et al., 2017). In this study the proportion of 
smokers was very low compared to the non-smokers. This may be due to the fact that this part of 
the world, women are less likely than men to be smokers and women formed the bulk of the 
respondents in this study. 
 
The most significant contributor to delay in presentation for treatment has been shown to be the 
duration between the onset of symptoms and the initial presentation for treatment at a health 
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facility (Fiona Walter et al., 2012). Most of the patients in this study waited for more than six 
months before presenting for treatment. Previous research has attributed this delay to issues such 
as wrong symptom appraisal and interpretation, competing priorities as is evident among patients 
with dependents and financial constraints and lack of social support, among others (Minghella 
Edana, Lakhani Mayur, Hughes Cathy, 2010).  
 
Some patients are also more likely to experience delay due to the unusual presentation of their 
disease while others such as those with breast lumps identify their symptoms early and thus 
avoid unnecessary delay for treatment. This study involved only those with advanced stages of 
disease thus did not compare disease specific delayed presentation. The study however identified 
cervical and breast cancer to be among the top cancers which corresponds with the national and 
international statistics in developing countries (WHO, 2014a). 
 
The main cancer treatment centers are located in Nairobi, that is, both public and private tertiary 
level facilities. Patients are referred from other counties all over the country to Nairobi when in 
need of cancer treatment services. Kenyatta National Hospital is the only public facility with the 
capability of offering both chemotherapy and radiotherapy, which are the two main forms of 
treatment for cancer patients. Patients who cannot afford to purchase healthcare from other 
similar cadre private hospitals such as Aga Khan University Hospital, MP Shah and Nairobi 
Hospital thus end up for treatment at KNH. Once the patients are reviewed by clinicians at KNH, 
they are referred to do imaging and laboratory investigations to corroborate the diagnosis and 
also for treatment planning. Not all patients are able to do these investigations in a timely manner 
as advised by the clinicians, mostly due to financial constraints (Ngugi et al., 2017). Thus the 
delay in getting the investigations done may also significantly contribute to the treatment delay. 
At the same time, patients found to have abnormalities in the laboratory or imaging results are 
often referred to other sections or providers to first address these abnormalities before the cancer 
treatment is initiated. 
 
It is notable that 58% of the participants in this study initially presented to private facilities for 
evaluation of their symptoms and 45% had their diagnosis made in private facilities. This may be 
evidence of a broken down public healthcare system within the country. There have been many 
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instances where public healthcare facilities lack basic facilities and supplies such as laboratory 
reagents and functional imaging machines and this can discourage the Kenyan citizens from 
seeking health care at the lower levels of hospitals such as county and sub-county hospitals. 
 
Scheduling to commence treatment is mostly done on a first-come first-served basis and 
occasionally based on the urgency of the symptoms; for example, patients with active bleeding 
or very severe pain are often prioritized over more stable patients. Due to the limited capacity for 
treatment at the facility, there is often a waiting list of around three to four weeks before the 
patients can finally commence their treatment. Most patients are currently paying for their cancer 
treatment through the National Hospital Insurance Fund (NHIF). Ordinarily most of the Kenyan 
patients are not aware, (Makau-Barasa et al., 2018) and do not subscribe to the National Health 
Insurance scheme (Chuma & Okungu, 2011; Nyorera & Okibo, 2015) until they are faced with 
illness such as a diagnosis of cancer. Upon diagnosis and the realization of the high costs of 
treatment they are advised at the hospitals to register with NHIF to help them meet their 
healthcare costs. For patients in the informal sector, the NHIF subscription takes around sixty 
days after registration before it is activated for use. A number of patients therefore also delay 
their initiation of treatment as they await the activation of their NHIF subscription. All these 
factors in addition to the health system factors may compound the treatment delay to longer than 
would be recommended for cancer patients. 
 
This study sought to describe the characteristics of patients presenting with advanced stages of 
cancer and was based on the findings of other studies that have been done in other parts of the 
world (Brown et al., 2014; Donkor et al., 2015; Rikke Pilegaard Hansen et al., 2008; Minghella 
E, Lakhani M, Hughes C, 2010; Olesen et al., 2009; Sarfati et al., 2016; Tiwari et al., 2015). The 
present study did not involve international comparisons, but the results indicated some themes 
that have also been associated with patient delay in other countries, such as lack of knowledge. It 
was a cross-sectional (descriptive) survey and thus direct causality cannot be inferred; 
knowledge about cancer may influence symptom interpretation and people who have known 
others with cancer may be more likely to be aware of the possible symptoms. Non-probability 
sampling also poses a challenge with generalizations. Being a retrospective study opens it to the 
risk of possible recall bias. Patient delay studies have been shown to be prone to the risk of 
39 
 
reduced reliability and validity (Andersen, Vedsted, Olesen, Bro, & Søndergaard, 2009). The use 
of structured questionnaires may be restrictive, in that, not all answers may be sufficiently 
accommodated. Some respondents may be „forced‟ to choose inappropriate pre-coded answers 
that may not fully represent their views (Bowling, 2014). This population is somewhat 
representative of the Kenyan population of cancer patients because most of them invariably end 
up at KNH for their treatment; both those who cannot afford private healthcare and those who 
exhaust their private insurance cover at the private facilities. The fact that the responses 
concerned actual experiences and help-seeking behavior from the respondents enhances the 






CONCLUSION AND RECOMMENDATION 
Cancer is gradually becoming a major public health issue in Kenya. This study corroborates the 
evidence that cancer is affecting the productive age groups which will adversely affect the 
overall economic productivity in the country. Delay in cancer diagnosis and treatment is an 
important factor for the overall outcome of the disease process (Caplan, 2014; Neal et al., 2015). 
Economic costs related to advanced stages of cancer include the higher costs of chemotherapy, 
radiation therapy and other relevant treatments, the loss of productivity due to morbidity and 
eventual mortality of those that fail to respond to the treatment (Africa & Initiative, 2014). 
Having been ranked among the top five causes of morbidity and mortality in Kenya thus 
indicates the weighty impact of the matter. The Ministry of Health in Kenya has a functional 
division of Non-Communicable Diseases (NCDs) and has been successful in releasing two 
cancer control strategy documents in 2011 and most recently in 2017. Efforts in cancer 
prevention and control by the Ministry of health have however been uncoordinated and mostly 
concentrated within Nairobi County. Early detection is one of the primary goals of cancer control 
as outlined in the National Cancer Control Strategy (MOH, 2017). Vaccination of young girls to 
reduce the incidence of cervical cancer and Hepatitis B vaccination for high risk workers such as 
those in health care; reduction of cigarette and alcohol use and maintaining a physically active 
lifestyle are among the primary prevention strategies advocated for in the NCCS. Proper 
planning and implementation of cancer control programs within the country is therefore of 
paramount importance.  
 
This descriptive survey of factors associated with late diagnosis and treatment of cancer patients 
has highlighted important characteristics among patients who present with advanced stages of 
disease. The knowledge and awareness levels on cancer, the possible risk factors and the 
available measures for early diagnosis remain significantly low among the Kenyan population. 
This highlights the need to intensify the awareness campaigns in all counties within the country. 
At the same time, an increase in awareness will herald an increased need to diagnose and treat 
the identified cases. The findings in this study corroborate the conclusions of studies done 
elsewhere that improving the levels of awareness of the early symptoms of cancer may increase 
people‟s ability to positively identify them and thus promote help-seeking (Busolo & Woodgate, 
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2015). However, it is also clear that creating awareness alone is insufficient to address delays 
and thus dealing appropriately with barriers to seeking medical care (cost, access and quality) 
will be required. Cancer control strategies within countries must prioritize primary and 
secondary prevention, alongside cancer management and palliative care and integrate these 
measures into existing health care plans (Bray, Jemal, Torre, Forman, & Vineis, 2015). 
There will thus be need to correspondingly build capacity for cancer treatment within the 
counties to reduce the high pressure laid on the two major referral facilities, that is Kenyatta 
National Hospital and Moi Teaching and Referral Hospital. This study has revealed a prolonged 
treatment delay which may be a consequence of several factors as highlighted in the discussion. 
Significantly also is the fact that radiation therapy for those who cannot afford to purchase 
healthcare privately is only available at KNH. The Ministry of Health needs to identify other 
regional facilities with adequate physical capacity and that would form an easier access point for 
the patients within those regions and set up the required radiation therapy services. Installation of 
radiation therapy equipment at MTRH also needs to be fast-tracked since part of the needed 
infrastructure is already in place. 
 
The study has also highlighted the need to ensure that the primary health care providers are well 
equipped to identify possible symptoms of cancer and be able to act on them or refer promptly to 
avoid undue delay to the cancer patients. The MoH should plan for and coordinate refresher 
courses for healthcare providers such as clinical officers and medical officers at primary and 
secondary level facilities to boost their clinical acumen and confidence in identification and 
initiation of relevant management for cancer patients.  
 
Further qualitative studies in evaluating the diagnostic and treatment delay are recommended to 
provide an in-depth analysis of the patients‟ experience and pathways to care. Research may also 
need to be conducted to quantify the actual delay related to access to care, in particular, the 
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PART ONE: SOCIOECONOMIC AND DEMOGRAPHIC CHARACTERISTICS 
A) PATIENT CHARACTERISTICS 
1 Age  
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11 Average weight at diagnosis:  
a) Overweight.  
b) Normal weight 
 
12 Dependents 





PART TWO: PATIENT, PHYSICIAN AND HEALTH SYSTEM FACTORS 
A) PATIENT KNOWLEDGE AND ATTITUDES 
1. Did you know about cancer before your diagnosis? 
a) Yes 
b) No                                                                                                                                            
 











If yes, how much do you agree that each of these measures can reduce the likelihood 
of getting cancer? 






Not smoking       
Reduced alcohol consumption      
Doing physical exercises      
Committing to one sexual partner      
Having a balanced diet      
Regular cancer screening      
Knowledge of family history      
 











There is no need for screening       
Screening services not available 
near me 
     
Cost of screening not affordable      
I have not heard of screening 
before 
     
 
5. How long (in days, months or years) before diagnosis had you experienced the 
symptoms? 
a) Less than 3 months 
b) 3 – 6 months 
c) 6 months – 1 Year 




6. Did you take any medications during onset of symptoms? 
a) Yes  
b) No 
 
(If YES above) Source of medications:  
a. Over the Counter. 
b. Herbal remedies 
c. Prescription medicine 
 
7. What is the cancer type (given by site of primary tumor, e.g. breast cancer)-------------
--------------------------------------------------------------------------------------- 
8. What is the cancer stage? ------------------------------------------------------------------------ 
 
PHYSICIAN AND HEALTH SYSTEM FACTORS 
1. Which was the first health facility you presented to after discovering the symptoms?  
a. Primary level public facility- dispensary, health center, sub-county hospital) 
b. Secondary level public facility- county referral hospital) 
c. Private facility  
d. Tertiary public facility 
e. Tertiary private facility 
 
2. In which health facility was your diagnosis of cancer made? 
a) Primary level public facility- dispensary, health center, sub-county hospital) 
b) Secondary level public facility- county referral hospital) 
c) Private facility  
d) Tertiary public facility 





3. How long did it take for you to know you have cancer? 
a. Less than 3 months 
b. 3 – 6 months 
c. More than 6 months 
d. Don‟t remember 
4. After receiving your diagnosis, how long did it take before you finally began 
receiving treatment? 
a. Less than 2 weeks 
b. 2 – 4 weeks 
c. 4 weeks – 3 months 
d. More than 3 moths 
5. Which of the following health system-related factors contributed most to your delay 







The health facility was far from 
where I live 
     
Treatment was not available at the 
hospital near me 
     
I was insufficiently evaluated by 
the medical practitioner 
     
I received the wrong diagnosis and  
treatment before I finally knew it 
was cancer 
     
Delay in referral to a more 
specialized hospital 
     
Long waiting times for specialized 
care 
     
My results were misplaced/got lost      
The medical practitioner did not 
explain the results to me to help 
me understand the urgency 
     
The cost of treatment was not 
affordable 




PARTICIPANT INFORMATION AND CONSENT SHEET: ENGLISH VERSION 
Factors associated with delay in presentation of cancer patients for treatment: A patient’s 
perspective 
Investigator: Ann Kabura 
Institutional affiliation: Strathmore Business School 
Dear participant, 
You are being invited to take part in a research study. Before participating in the study, please 
take time to read the following information carefully. 
What is the purpose of the study? 
The purpose of this study is to understand what factors lead to delayed presentation for treatment 
among cancer patients in Kenya. The results will be used to develop better and more effective 
hospital and countrywide interventions and services towards early diagnosis of cancer. 
Who is eligible to participate? 
All adult patients with cancer coming to start treatment will be eligible to participate in this 
study.  
Do I have to take part? 
Taking part is voluntary. If you do decide to take part you will be given this information sheet to 
keep and be asked to sign as evidence of your consent. You will then be guided through some 
questions to get information on factors that may have contributed to the time you took before 
starting your treatment. There are no risks in taking part in this study 
Confidentiality 
All the information that is collected will be anonymous and kept strictly confidential. Your 
personal data will be held in accordance with the principles of confidentiality in research. 
Benefits 
The findings of this study will help us to build our understanding of patients‟ pathways to cancer 
treatment so that we can develop ways to improve cancer services and the overall patient 
outcomes in our country. In the future, researchers will also be able access and read the findings 





In case of any further questions:  
You can contact me, Ann Kabura, by email kaburaann@yahoo.com or by phone 0723717870 
You can also contact my supervisor Dr. Vincent O., by email vokungu@strathmore.edu  
 
If you want to ask someone independent anything about this research please contact:  
The Secretary–Strathmore University Institutional Ethics Review Board, P. O. BOX 59857, 




I ______________________ have read/understood the contents in this form. My questions have 
been answered. I agree to participate in this study. 
 
Signature of Participant _________________________ 
Signature of witness (if participant cannot read) ________________________ 
Signature of researcher _________________________ 















INFORMATION AND CONSENT SHEET: SWAHILI VERSION 
Ridhaa ya Kushiriki katika utafiti huu  
Habari, umealikwa kuhusika katika mradi huu wa utafiti wenye lengo la kukusanya maoni toka 
kwa wagonjwa wa saratani kuhusu sababu zinazosababisha wagonjwa wa saratani kuchelewa 
kupata matibabu. Unaombwa kushiriki katika utafiti huu kwa sababu una uelewa na ambao 
unaweza kuwa muhimu katika tafiti hii. 
Nakuhakikishia kwamba taarifa zote zitakazokusanywa kutoka kwako zitakua ni siri, ni watu 
wanaofanya kazi katika utafiti huu tu ndio wanaweza kuziona taarifa hizi. Hatutaweka jina lako 
au taarifa yoyote ya utambulisho kwenye kumbukumbu za taarifa utakazotupa. Unaweza kukataa 
kujibu swali lolote na unaweza kusimamisha usaili wakati wowote. 
Taarifa utakayotupatia itasaidia kuongeza uelewa wetu kuhusu kuhusu sababu zinazosababisha 
wagonjwa wa saratani kuchelewa kupata matibabu na kufika wakati saratani iko kwenye hatua 
ambayo ni vigumu kutibika. Pia taarifa hizi zitasaidia katika kutayarisha mipango, mikakati na 
sera kwa wagonjwa wa saratani nchini yetu. 
 
Sahihi  
Mimi ______________________ nimesoma na nimeielewa hii fomu. Maswali yangu 
yamejibiwa. Nakubali kushiriki katika utafiti huu.  
 
Sahihi ya mshiriki _________________________  
 
Sahihi ya shahidi (kama hawezi kusoma na kuandika) _________________________  
 
Sahihi ya mtafiti mwandamizi _________________________  
 
Tarehe ya makubaliano _________________________ 
